Amgen (AMGN) reports Q3: everything you need to know ahead of earnings
Published . Updated .
Covered by 3 outlets: Yahoo Finance, FinancialContent, TradingView.
Who covered it: Center 1 · Not rated 2. How we rate outlets
Market Call
Think this story will push the stock up or down over the next three trading days? Make a free call and see what other readers think. Points are play money with no cash value.
Get these market calls by email
The week's biggest market-moving stories, Congress trades and Trump posts, with the tickers they touch. Free, one email a week.
Free. We only use your email to send the digest, never sell or share it, and every email has a one-click unsubscribe link. See our privacy policy.
This report does not map to a usual set of affected companies.
Directly affected
- AMGN Amgen+15.9% 30d
Named in this report.
Indirectly affected
- XLV Health Care Select Sector SPDR
Health Care Select Sector SPDR holds the health sector that Amgen belongs to, so it often moves with news about it.
- GILD Gilead Sciences+16.4% 30d
Gilead Sciences is a peer of Amgen in biological products, (no diagnostic substances); rivals often move on the same news.
- MRNA Moderna+22.4% 30d
Moderna is a peer of Amgen in biological products, (no diagnostic substances); rivals often move on the same news.
- ARGX argenx SE-11.9% 9d
argenx SE is a peer of Amgen in biological products, (no diagnostic substances); rivals often move on the same news.
- RVMD Revolution Medicines
Revolution Medicines is a peer of Amgen in biological products, (no diagnostic substances); rivals often move on the same news.
- BIIB Biogen+12.4% 30d
Biogen is a peer of Amgen in biological products, (no diagnostic substances); rivals often move on the same news.
Price reaction, T-5 to T+3
| Ticker | T-5 | T-3 | T-1 | T0 | T+1 | T+2 | T+3 |
|---|---|---|---|---|---|---|---|
| AMGN | -4.55% | -3.07% | base | -0.14% | -1.06% | +2.57% | -1.20% |
| XLV | -3.03% | -2.77% | base | -0.14% | -0.48% | +2.59% | +0.17% |
| GILD | -7.17% | -6.85% | base | -0.33% | -2.02% | +2.05% | -2.01% |
| MRNA | -10.32% | -3.42% | base | -0.33% | +3.06% | +16.60% | +8.93% |
| ARGX | -2.70% | -0.16% | base | -2.03% | +0.94% | +4.33% | +0.15% |
| RVMD | -3.96% | -1.41% | base | -1.67% | +1.47% | +4.26% | -7.06% |
| BIIB | -0.52% | -3.69% | base | -1.87% | -1.83% | +0.36% | -3.81% |
Closing-price change versus T-1, the last close before the story. T0 to T+3 fill in after each market close. Prices: Alpaca IEX.
Amgen (AMGN) reports Q3: everything you need to know ahead of earnings Yahoo Finance
Source: Yahoo Finance
This story
| Company | When | Move | Status |
|---|---|---|---|
| AMGN | that day | -0.14% | final price |
| AMGN | the next day | -1.06% | final price |
| AMGN | two days later | +2.57% | final price |
| AMGN | three days later | -1.20% | final price |
| AMGN | three days earlier | -3.07% | final price |
| AMGN | five days earlier | -4.55% | final price |
| ARGX | that day | -2.03% | final price |
| ARGX | the next day | +0.94% | final price |
| ARGX | two days later | +4.33% | final price |
| ARGX | three days later | +0.15% | final price |
| ARGX | three days earlier | -0.16% | final price |
| ARGX | five days earlier | -2.70% | final price |
| BIIB | that day | -1.87% | final price |
| BIIB | the next day | -1.83% | final price |
| BIIB | two days later | +0.36% | final price |
| BIIB | three days later | -3.81% | final price |
| BIIB | three days earlier | -3.69% | final price |
| BIIB | five days earlier | -0.52% | final price |
| GILD | that day | -0.33% | final price |
| GILD | the next day | -2.02% | final price |
| GILD | two days later | +2.05% | final price |
| GILD | three days later | -2.01% | final price |
| GILD | three days earlier | -6.85% | final price |
| GILD | five days earlier | -7.17% | final price |
| MRNA | that day | -0.33% | final price |
| MRNA | the next day | +3.06% | final price |
| MRNA | two days later | +16.60% | final price |
| MRNA | three days later | +8.93% | final price |
| MRNA | three days earlier | -3.42% | final price |
| MRNA | five days earlier | -10.32% | final price |
| RVMD | that day | -1.67% | final price |
| RVMD | the next day | +1.47% | final price |
| RVMD | two days later | +4.26% | final price |
| RVMD | three days later | -7.06% | final price |
| RVMD | three days earlier | -1.41% | final price |
| RVMD | five days earlier | -3.96% | final price |
| XLV | that day | -0.14% | final price |
| XLV | the next day | -0.48% | final price |
| XLV | two days later | +2.59% | final price |
| XLV | three days later | +0.17% | final price |
| XLV | three days earlier | -2.77% | final price |
| XLV | five days earlier | -3.03% | final price |
Congressional trades in the stocks in this story
- Rep. David J. Taylor sold Amgen (AMGN), worth $1,001 - $15,000 on 3 Nov 2026. That is 1 days after publication. Filed 12 Nov 2026. View the filing.
- Sen. Sheldon Whitehouse sold Amgen (AMGN) (held by a spouse), worth $15,001 - $50,000 on 15 Oct 2026. That is 18 days before publication. Filed 2 Nov 2026. View the filing.
- Rep. David J. Taylor bought Amgen (AMGN), worth $1,001 - $15,000 on 22 Sep 2026. That is 41 days before publication. Filed 1 Oct 2026. View the filing.
- Rep. Rohit Khanna sold Gilead Sciences (GILD) (held by a dependent child), worth $1,001 - $15,000 on 10 Aug 2026. That is 84 days before publication. Filed 4 Sep 2026. View the filing.
- Rep. Gilbert Cisneros bought Moderna (MRNA), worth $1,001 - $15,000 on 20 Oct 2026. That is 13 days before publication. Filed 10 Nov 2026. View the filing.
- Rep. Maria Elvira Salazar sold Moderna (MRNA), worth $1,001 - $15,000 on 24 Sep 2026. That is 39 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Rohit Khanna bought Moderna (MRNA) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 59 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Gilbert Cisneros bought Argenx Se (ARGX), worth $1,001 - $15,000 on 27 Oct 2026. That is 6 days before publication. Filed 10 Nov 2026. View the filing.
- Rep. Gilbert Cisneros bought Argenx Se (ARGX), worth $1,001 - $15,000 on 15 Oct 2026. That is 18 days before publication. Filed 10 Nov 2026. View the filing.
- Rep. Gilbert Cisneros bought Argenx Se (ARGX), worth $15,001 - $50,000 on 14 Oct 2026. That is 19 days before publication. Filed 10 Nov 2026. View the filing.
- Rep. Maria Elvira Salazar sold Biogen (BIIB), worth $1,001 - $15,000 on 24 Sep 2026. That is 39 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Rohit Khanna bought Biogen (BIIB) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 59 days before publication. Filed 7 Oct 2026. View the filing.
Public disclosure filings, not a recommendation. The filing link is the source document. News use of these reports still sits under 5 U.S.C. § 13107(c).
This story
38 out of 100
“Amgen (AMGN) reports Q3: everything you need to know ahead of earnings” scores 38 out of 100. The score uses 3 sources.